Thomas Mullen

Thomas Mullen

Company: SeQure Dx

Job title: Chief Scientific Officer


One Genome or Thousands of Genomes? The importance of evaluating population variants 1:40 pm

What does the FDA gene-editing draft guidance ask for? Why are population variants important for off-target risk assessments? Methods to efficiently generate and match risk assessments with the intent to treat populationRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.